Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib vs placebo in mastocytosis with handicap
2008-000972-25Phase 3Completed
- Sponsor
- AB Science
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in mastocytosis and cutaneous mastocytosis (CM) comparing Masitinib arm with Placebo arm (2 arms). Primary endpoint: Responder rate. Started May 2008; status: completed.
02
Drugs
masitinib
03
Conditions
mastocytosiscutaneous mastocytosis (CM)
Beyond the preview
Go deeper on 2008-000972-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000972-25.